Article
Hereditary angioedema: the clinical syndrome and its management in the United States.
Immunology and allergy clinics of North America - 1 Nov 2006
Frank Michael M
Abstract excerpt
There have been important breakthroughs in the understanding and treatment of hereditary angioedema (HAE). An associated abnormality of the serum protein C1 inhibitor led to purified protein use to end attacks. Consideration of the endocrine functions led to rediscovery of impeded androgen use in disease prophylaxis. Considerations of pathophysiology led to introduction of epsilon aminocaproic and tranexemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
